2016年江蘇盛澤醫(yī)院住院患者華法林用藥調(diào)查

沈曉嵐; 朱小芬; 張蕾; 姜桐桐; SHEN Xiao-lan; ZHU Xiao-fen; ZHANG Lei; JIANG Tong-tong

溫馨提示：建議您使用Chrome80、火狐74+、IE9+瀏覽器，當(dāng)您的瀏覽器版本過低，可能會影響部分功能正常使用。

主辦：天津藥物研究院中國藥學(xué)會

微信公眾號

網(wǎng)站二維碼

首頁 > 過刊瀏覽>2018年第41卷第1期 >2018,41(1):147-151. DOI:10.7501/j.issn.1674-6376.2018.01.028

2016年江蘇盛澤醫(yī)院住院患者華法林用藥調(diào)查

Investigation of warfarin use in inpatients of Jiangsu Shengze Hospital in 2016

發(fā)布日期：2018-03-17

摘要
圖/表
訪問統(tǒng)計
PDF預(yù)覽
參考文獻(xiàn)
相似文獻(xiàn)
引證文獻(xiàn)
附件

[關(guān)鍵詞]

[摘要]

目的調(diào)查2016年江蘇盛澤醫(yī)院住院患者接受華法林治療情況，了解該藥的實(shí)際應(yīng)用情況和用藥誤區(qū)，尋找監(jiān)護(hù)要點(diǎn)。方法通過醫(yī)院HIS系統(tǒng)及電子病歷系統(tǒng)收集2016年1月1日-12月31日于江蘇盛澤醫(yī)院住院期間使用華法林的患者的病例信息，分析其人口學(xué)資料、檢驗指標(biāo)、用藥診斷、合并用藥、不良反應(yīng)發(fā)生情況。結(jié)果 江蘇盛澤醫(yī)院服用華法林患者群以房顫、老年患者最多，肝腎功能異常的患者占有一定比例，但華法林并未造成肝腎功能繼續(xù)惡化。結(jié)論 該院華法林使用較為合理，用藥監(jiān)護(hù)的重點(diǎn)對象為房顫、老年、肝腎功能異?；颊摺?/div>

[Key word]

[Abstract]

objective To Investigate inpatients of Jiangsu Shengze Hospital with the treatment of warfarin in 2016 and understand the actual application and misunderstanding of warfarin, looking for the main points of drug monitoring in warfarin use. Methods Through HIS system and EMR system, the use of warfarin in the inpatients case information from January 1 to December 31 in 2016 was collected. Moreover, demographic data, test index, diagnosis, combination medication, and adverse reactions were analyzed. Results Most patients used warfarin are patients with atrial fibrillation, advanced age, and the number of patients with abnormal liver and kidney function account for a certain percentage in Jiangsu Shengze Hospital. Conclusions The future work of drug monitoring in warfarin use mainly focus on the patients with atrial fibrillation, advanced age and abnormal liver and kidney function.

[中圖分類號]

[基金項目]

吳江區(qū)衛(wèi)生局“科教興衛(wèi)”研究項目（WWK201413）